Transave Inhalation Biopharmaceuticals
Latest round
- Series D
Last raised
- Mar 2008
Total raised
- $67M
Investors
- 9
About Transave Inhalation Biopharmaceuticals
Transave Inhalation Biopharmaceuticals is a US-based company that operates as a provider of inhaled pharmaceuticals for the treatment of lung diseases.
Who invested in Transave Inhalation Biopharmaceuticals
9 investors across 4 rounds
See all investors in Transave Inhalation Biopharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Transave Inhalation Biopharmaceuticals
Who invested in Transave Inhalation Biopharmaceuticals?
Transave Inhalation Biopharmaceuticals has 9 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Transave Inhalation Biopharmaceuticals raised?
Transave Inhalation Biopharmaceuticals has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Transave Inhalation Biopharmaceuticals last raise money?
Transave Inhalation Biopharmaceuticals's most recent round on record is a Series D, in Mar 2008.
What does Transave Inhalation Biopharmaceuticals do?
Transave Inhalation Biopharmaceuticals is a US-based company that operates as a provider of inhaled pharmaceuticals for the treatment of lung diseases.
Where is Transave Inhalation Biopharmaceuticals headquartered?
Transave Inhalation Biopharmaceuticals is headquartered in US.
Which VCs invest in companies like Transave Inhalation Biopharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Transave Inhalation Biopharmaceuticals's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like Transave Inhalation Biopharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.